Myeloablative and immunosuppressive properties of treosulfan in mice. - Wikidata - wikimedia - TriplyDB

Myeloablative and immunosuppressive properties of treosulfan in mice.

Myeloablative and immunosuppressive properties of treosulfan in mice.

http://www.wikidata.org/entity/Q42168522

about

Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial.Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial.Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer.Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.Safety of conditioning agents for allogeneic haematopoietic transplantation.High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation.Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike.Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning.Treosulfan-Based Conditioning Regimen in Sibling and Alternative Donor Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease.Fludarabine and treosulfan compared with other reduced-intensity conditioning regimens for allogeneic stem cell transplantation in patients with lymphoid malignancies.Preclinical analysis of treosulfan in combination with total body irradiation as conditioning regimen prior to bone marrow transplantation in rats.Hematopoietic stem cell transplantation for primary immunodeficiency diseases.Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes.Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning.High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre study.Treosulfan-based conditioning regimens for allogeneic haematopoietic stem cell transplantation in children with non-malignant diseases.Comparison of algorithms for oral busulphan area under the concentration-time curve limited sampling estimate.Treosulfan induces distinctive gonadal toxicity compared with busulfan.

P2860

Q34358241-61D95D21-E94E-42BF-9B2B-54C20D57B33D Q35073850-BA19BC60-07BF-4663-B1AB-C3DB5F3045FF Q35193735-AD9CA38C-6E2D-4995-8B16-2D4F543B6FBF Q35551845-DA4AE3D7-F31E-4893-9BE3-28C42105B287 Q37415420-C3A3EB23-8B9F-4437-A379-36F391575822 Q37510948-D25EA9F0-36DE-4657-8D4F-3A82DA5A96FC Q37788219-0C2B04B5-B7D8-486B-B2AE-2C00729AD9B3 Q37863461-174B0E95-0DCA-4A5D-8AC2-D7E202E44DAE Q38479720-82FA23EA-B8EA-4616-9499-E6C380C07403 Q38908093-FB0D41C3-BAC7-475E-B01F-CCF26EA667CE Q41519709-E09BA1CF-E4E5-40DB-B013-3F0223829CBA Q43252740-6D2E5743-A954-47C5-AD0A-B14111906FF0 Q44797357-7B02F773-C0F1-4FE8-ABD4-CE670124404E Q46860359-1BEF5CCE-69BB-49C5-AEDD-69A1DC6F80A3 Q47724804-9253771D-4D25-4981-9954-1541113CB5F5 Q47763046-DD74AFF0-6E5C-4771-8795-636D043D361F Q48148219-5D56F02B-4CA3-460A-AF36-6C3517CEECE3 Q51146472-F380D733-2BCE-45E9-8AF8-538E79D6EF69 Q55263709-979B7142-5445-4032-947A-0B4CBB0CA42D

P2860

Myeloablative and immunosuppressive properties of treosulfan in mice.

http://www.wikidata.org/entity/Q42168522

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Myeloablative and immunosuppressive properties of treosulfan in mice.

@en

Myeloablative and immunosuppressive properties of treosulfan in mice.

@nl

type

label

Myeloablative and immunosuppressive properties of treosulfan in mice.

@en

Myeloablative and immunosuppressive properties of treosulfan in mice.

@nl

prefLabel

Myeloablative and immunosuppressive properties of treosulfan in mice.

@en

Myeloablative and immunosuppressive properties of treosulfan in mice.

@nl

P1433

Q42168522-47EF6C9F-BEDA-48BC-BDC6-A98DDE6F974A

P1476

Q42168522-5EB54C8B-0502-4D68-BF2D-B81E0C153AE2

P2093

Q42168522-0974DB98-437B-415F-9B5A-E8C962875560

Q42168522-0E52203A-D75D-4B1D-98CD-C0BC854D3DA4

Q42168522-1EC79F84-6D5F-4004-BF7E-68A6C9241816

Q42168522-7932CD7D-ED60-4B64-B4B8-3DAF3391121C

Q42168522-7A3E8475-0E28-49F7-88EB-CBFF37F22993

Q42168522-989C67A8-D1D2-4DD3-8BE0-A2AF5773F8B6

Q42168522-DEACBBBB-427D-4CE5-8B49-5621F50165EB

Q42168522-DF330C8C-8038-488C-B252-446542AC71B4

Q42168522-F19ACA70-9196-4698-B9A0-CA2E91864171

P304

Q42168522-D0B5E69A-C8BC-4EAD-93D1-F0CD43274FB2

P31

Q42168522-08C7E365-85E1-4368-AAE4-AC98F6BE315B

P356

Q42168522-8E35564E-EF48-4F97-8B8E-4EACA4007C47

P433

Q42168522-A6B69ECB-7F91-40C8-9031-7FE6066B6858

P478

Q42168522-F1986217-EC64-466B-803E-58EAD3501320

P50

Q42168522-9B43ABF8-2B59-4FF1-B323-3E0672FD3238

P577

Q42168522-521EA26F-F464-41FF-B733-165A005B6606

P698

Q42168522-2BFA6CE8-6EEB-41B0-B072-ED2537FAAB96

P356

J.EXPHEM.2005.09.015

P1433

Experimental Hematology

P1476

Myeloablative and immunosuppressive properties of treosulfan in mice.

@en

P2093

Christina Nilsson

http://www.w3.org/2001/XMLSchema#string

Fredrik Sjöö

http://www.w3.org/2001/XMLSchema#string

Hernan Concha

http://www.w3.org/2001/XMLSchema#string

Johan Aschan

http://www.w3.org/2001/XMLSchema#string

Laimonas Griskevicius

http://www.w3.org/2001/XMLSchema#string

Manuchehr Abedi-Valugerdi

http://www.w3.org/2001/XMLSchema#string

Mats Remberger

http://www.w3.org/2001/XMLSchema#string

Una Gaughan

http://www.w3.org/2001/XMLSchema#string

Zuzana Hassan

http://www.w3.org/2001/XMLSchema#string

P304

115-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPHEM.2005.09.015

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Moustapha Hassan

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16413398

http://www.w3.org/2001/XMLSchema#string